Stryker introduced the TPX HD, a premium small bone power tool designed to enhance performance, control, and ergonomics in demanding orthopedic procedures like total joint revisions and minimally invasive surgeries. The tool offers up to 296% more torque and 40% faster performance than its predecessor, with customizable controls and specialized attachments for various surgical needs. This launch aims to improve surgical precision and usability in challenging environments, supporting better patient outcomes.
Stryker reported a 7.7% increase in net sales to $6.5 billion for Q3 2026, driven by organic growth in MedSurg, Neurotechnology, and Orthopaedics. Adjusted earnings per share rose 10.3% to $3.52, reflecting strong operational performance, while repor...
Stryker Corporation, a global leader in medical technologies, reported a 6.1% increase in revenue and EBITDA of $3.45 billion for the first half of 2026. Management forecasts organic revenue growth between 8.3% and 9.3% for the full year, with adjust...
Stryker Corporation has finalized its acquisition of ZuriMED, incorporating the FiberLocker System into its Sports Medicine offerings. This technology enhances rotator cuff repair by improving biomechanical strength, addressing a key clinical need. T...
